# Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

> **NCT00246376** · NA · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 221 (actual)

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- HIV Infections
- Hyperlipidemia
- Hypertriglyceridemia
- Insulin Resistance
- Atherosclerosis

## Interventions

- **BEHAVIORAL:** Diet
- **BEHAVIORAL:** Exercise
- **DRUG:** Niacin
- **DRUG:** Fenofibrate
- **OTHER:** Placebos

## Key facts

- **NCT ID:** NCT00246376
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2009-09
- **Final completion:** 2012-02
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2016-03-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246376, "Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00246376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
